Minnesota biotech firm Vyriad raises $29.5 million for cancer-fighting viruses By: Minneapolis / St. Paul Business Journal via Business Journals May 17, 2022 at 16:33 PM EDT Vyriad Inc., a company that's engineering cancer-killing viruses, announced Tuesday it raised $29.5 million in Series B funding. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
